Hypothalamic-pituitary-adrenal axis stress test in patients with early RA: Role of corticotropinreleasing hormone promoter polymorphisms

Annals of the Rheumatic Diseases

Volumn 70, Issue 11, 2011, Pages 2058-2059

  Malysheva, O ^a   Wagner, U ^a,a   Wahle, M ^b   Pierer, M ^a   Stalla, G K ^c   Baerwald, C G O ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; GLUCOSE; HYDROCORTISONE; INSULIN;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN RELEASING HORMONE GENE; DISEASE ACTIVITY; EXERCISE TEST; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN HYPOGLYCEMIA TEST; LETTER; MOLECULAR PATHOLOGY; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; RHEUMATOID ARTHRITIS;

ADULT; ARTHRITIS, RHEUMATOID; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PILOT PROJECTS; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, GENETIC;

EID: 80053566042     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.151340     Document Type: Letter

References (10)

1. Elenkov IJ. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 2008;52:40-51. (Pubitemid 350235704)
2. Straub RH, Pongratz G, Hirvonen H, et al. Acute cold stress in rheumatoid arthritis inadequately activates stress responses and induces an increase of interleukin 6. Ann Rheum Dis 2009;68:572-8.
3. Capellino S, Cosentino M, Wolff C, et al. Catecholamine-producing cells in the synovial tissue during arthritis: modulation of sympathetic neurotransmitters as new therapeutic target. Ann Rheum Dis 2010;69:1853-60.
4. Malysheva O, Pierer M, Wagner U, et al. Association between beta2 adrenergic receptor polymorphisms and rheumatoid arthritis in conjunction with human leukocyte antigen (HLA)-DRB1 shared epitope. Ann Rheum Dis 2008;67:1759-64.
5. Härle P, Straub RH, Wiest R, et al. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann Rheum Dis 2006;65:51-6. (Pubitemid 41815639)
6. Bornstein SR, Engeland WC, Ehrhart-Bornstein M, et al. Dissociation of ACTH and glucocorticoids. Trends Endocrinol Metab 2008;19:175-80. (Pubitemid 351847836)
7. Wagner U, Wahle M, Moritz F, et al. Promoter polymorphisms regulating corticotrophin-releasing hormone transcription in vitro. Horm Metab Res 2006;38:69-75.
8. Baerwald CG, Mok CC, Fife MS, et al. Distribution of corticotropin- releasing hormone promoter polymorphism in different ethnic groups: evidence for natural selection in human populations. Immunogenetics 1999;49:894-9. (Pubitemid 29381452)
9. Straub RH, Pongratz G, Cutolo M, et al. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Rheum 2008;58:976-84. (Pubitemid 351563998)
10. Cutolo M, Straub RH, Bijlsma JW. Neuroendocrine-immune interactions in synovitis. Nat Clin Pract Rheumatol 2007;3:627-34. (Pubitemid 350031752)